A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of PUR0200. In addition,
the study will look at the blood levels of different doses of PUR0200 and their affect on
lung function in COPD patients.